Demonstrates durable bioactive textiles with antibacterial and antiviral effects, suggesting sustainable alternatives.
The growing demand for durable and environmentally sustainable bioactive textiles has created a need for functionalization strategies that minimize the release of active agents during use and laundering. In this study, a novel chloroxylenol-functionalized vinyl sulfone reactive dye was synthesized through the coupling of chloroxylenol with diazotized para-ester and characterized using FTIR, UV–Vis, 1H-NMR, and 13C-NMR spectroscopy. The synthesized dye was applied to cotton fabric through an exhaust dyeing process, enabling simultaneous coloration and biofunctionalization in a single step. The dye exhibited high substantivity toward cotton, achieving dye exhaustion and fixation values of 95% and 91%, respectively. The dyed fabric demonstrated excellent antibacterial activity against Staphylococcus aureus (99.99%) and Escherichia coli (94%), antiviral activity of 87%, and antifungal activity of 86% before laundering. After 20 laundering cycles, antibacterial activity remained at 96% against S. aureus and 91% against E. coli, while antiviral and antifungal activities remained at 83% and 82%, respectively, confirming the durability of the bioactive functionality. Optical density measurements further verified substantial bacterial growth inhibition, whereas MTT assays using L929 fibroblasts demonstrated acceptable biocompatibility with cell viability exceeding 80% at the highest tested concentration. The dyed fabrics also exhibited excellent ultraviolet protection (UPF 119) with UVA and UVB blocking efficiencies of 99.35% and 98.98%, respectively, together with good colorfastness properties. Furthermore, UV–Vis analysis of the washing liquor indicated negligible dye release under the investigated laundering conditions. These findings demonstrate an effective and sustainable one-step strategy for producing durable multifunctional bioactive textiles while reducing processing steps and minimizing the potential release of active agents during use.
No takes yet. Share an insight, caveat, or question.
Nosheen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: